The neurological complications of systemic sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 20, Issue 2, 2003, Pages 85-94

  Kidd, Desmond ^a   Beynon, Huw L C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Neurosarcoidosis; Sarcoidosis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOLIC ACID; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID; PENTOXIFYLLINE; PREDNISOLONE; STEROID; THALIDOMIDE;

BRAIN DISEASE; BRAIN INFARCTION; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NEUROPATHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; GRANULOMATOSIS; HUMAN; HYDROCEPHALUS; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LABORATORY DIAGNOSIS; MENINGITIS; MONONEUROPATHY MULTIPLEX; MUSCLE DISEASE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RADICULOPATHY; REVIEW; SARCOIDOSIS; SIDE EFFECT; SPINAL CORD LESION; SYSTEMIC DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROCEPHALUS; HYPOTHALAMUS; NERVOUS SYSTEM DISEASES; SARCOIDOSIS; SYNDROME;

EID: 0037927568     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Siltzbach LE, James DG, Neville E, et al: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57(6): 847-52.
2. James DG, Hosoda Y: Epidemiology. In: James DG, ed. Sarcoidosis and other granulomatous disorders. New York, Marcel Dekker, 1994: 729-43.
3. Selroos O: The frequency clinical picture and prognosis of pulmonary sarcoidosis in Finland. Acta Med Scand 1969; 186 (suppl): 503.
4. Scott TF: Neurosarcoidosis: progress and clinical aspects. Neurology 1993; 43: 8-12.
5. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J: Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42: 909-16.
6. Chen RCY, McLeod JG: Neurological complications of sarcoidosis. Clin Exp Neurol 1989; 26: 99-112.
7. Colover J: Sarcoidosis with involvement of the nervous system. Brain 1948; 71: 451-61.
8. Aszkanazy CL: Sarcoidosis of the central nervous system. J Neuropathol Exp Neurol 1952; 11: 392-400.
9. Maycock RL, Bertrand P, Morrison CE, Scott JH: Manifestations of sarcoidosis. Analysis of 145 patients with a review of nine series selected from the literature. Am J Med 1963; 35: 67-89.
10. Herring AB, Urich H: Sarcoidosis of the central nervous system. J Neurol Sci 1969; 9: 405-22.
11. Oksanen V: Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 1986; 73: 283-90.
12. Zajicek JP, Scolding NJ, Foster O, et al: Central nervous system sarcoidosis - diagnosis and management. QJ Med 1999; 92: 103-17.
13. Ferriby D, de Seze J, Stojkovic T, et al: Long-term follow-up of neurosarcoidosis. Neurology 2001; 57: 927-9.
14. Ricker W, Clark M: Sarcoidosis; a clinicopathologic review of three hundred cases, including twenty two autopsies. Am J Clin Path 1949; 19: 725-49.
15. Waxman JS, Hollenberg Sher J: The spectrum of central nervous system sarcoidosis. A Clinical and pathologic study. Mt Sinai J Med 1979; 46 (3): 309-17.
16. Case records of the Massachusetts General Hospital (case 37-1996) N Engl J Med 1996; 335: 1668-74.
17. Manz HJ: Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci 1983; 10: 50-5.
18. Hagerstrand I, Linell F: The prevalence of sarcoidosis in the autopsy material from a Swedish town. Acta Med Scand 1964; 425 (suppl): 171-3.
19. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y: Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993; 43: 372-276.
20. Chapelon C, Ziza JM, Piette JC, et al: Neurosarcoidosis signs, course and treatment in 35 confirmed cases. Medicine 1990; 69: 261-76.
21. Lower EE, Broderick JP, Brott, TG, Baughman RP: Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157: 1864-8.
22. Sharma OP: Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest 1997; 112: 220-8.
23. Oksanen V, Saimi T: Visual and auditory evoked potentials in the early diagnosis and follow-up of neurosarcoidosis. Acta Neurol Scand 1986; 74: 38-42.
24. Oki M, Takizuri S, Ohnuki Y, et al: MRI findings of VIIth cranial nerve involvement in sarcoidosis. Br J Radiol 1997; 70: 859-61.
25. Ueyama H, Kumamoto T, Fukudi S, et al: Isolated third nerve palsy due to sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 169-70.
26. Sugaya F, Shubito N, Takahashi H, Abe S: Sudden hearing loss as the initial manifestation of neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 54-6.
27. Souliere CR, Kava CR, Barrs DM, Bell AF: Sudden hearing loss as the sole manifestation of neurosarcoidosis. Otolaryngol - Head & Neck Surg 1991; 105 (3): 376-81.
28. Tyndel FJ, Davidson GS, Birman H, Modzelewski ZA, Acker JJ: Sarcoidosis of the middle ear. Chest 1994; 105(5): 1582-3.
29. Kane K: Deafness in sarcoidosis. J Laryngol Otol 1976; 90 (6): 531-7.
30. Babin RW, Liu C, Aschenbrener C: Histopathology of neuro-sensory deafness in sarcoidosis. Ann Otol Rhinol Laryngol 1984; 93: 389-93.
31. Hooper R, Holden H: Acoustic and vestibular problems in sarcoidosis. Arch Otolaryngol 1990; 92: 386-91.
32. Von Brevern M, Lempert T, Bronstein AM, Kocen R: Selective vestibular damage in neurosarcoidosis. Ann Neurol 1997; 42: 117-20.
33. Hybels RL, Rice DH: Neuro-otologic manifestations of sarcoidosis. Laryngoscope 1976; 86 (12): 1873-8.
34. Delaney P: Neurologic manifestations of sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87: 336-46.
35. Blain JG, Riley W, Logothetis J: Optic nerve manifestations of sarcoidosis. Arch Neurol 1965; 13: 307-9.
36. Bardelli AM, Barberi L, Vanni M, Mazzera L, Traversi C: Eye involvement in sarcoidosis: survey of 197 patients. Sarcoidosis Vasc Diffuse Lung Dis 1993;10 (2): 158-9.
37. Obenauf CD, Shaw HE, Syndor CF, Klintworth GK: Sarcoidosis and its ophthalmic manifestations. Am J Opthalmol 1978; 86 (5): 648-55.
38. O'Brien GM, Baughman RP, Broderick SP, Arnold L, Lower EE: Paranoid psychosis due to neurosarcoidosis. Sarcoidosis 1994; 11: 34-6.
39. Powers WJ, Miller EM: Sarcoidosis mimicking glioma: case report and review of the intracranial sarcoid mass lesions. Neurology 1981; 31: 907-10.
40. Cahill DW, Salcman M: Neurosarcoidosis: A review of the rarer manifestations. Surg Neurol 1981; 15: 204-11.
41. Jackson RJ, Goodman SL, Huston DS, Harper RL: Parafalcine and bilateral convexity neurosarcoidosis mimicking meningioma: case report and review of the literature. Neurosurgery 1998; 42 (3): 635-8.
42. Clark WC, Acker JD, Dohan FC, Robertson JH: Presentation of central nervous system sarcoidosis as intracranial tumors. J Neurosurg 1985; 63: 851-6.
43. Karnik, AS: Nodular cerebral sarcoidosis simulating metastatic carcinoma. Arch Intern Med 1982; 142: 385-6.
44. Krumholz, A, Stern BJ, Stern EG: Clinical implications of seizures in neurosarcoidosis. Arch Neurol 1991; 48: 842-5.
45. Silverstein A, Feuer MM, Siltzbach LE. Neurological sarcoidosis. Arch Neurol 1965; 12: 1-11.
46. Rubinstein I, Gray TA, Moldofsky H, Hoffstein V: Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest 1988; 94 (1): 205-6.
47. Stuart CA, Neelon FA, Lebovitz HE: Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis. Ann Intern Med 1978; 88 (5): 589-94.
48. Ingestad R, Stigmar G: Sarcoidosis with ocular and hypothalamic - pituitary manifestations. Acta Ophthalmologica 1971; 49: 1-10.
49. Lipton JM, Kirkpatrick J, Rosenberg RN: Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol 1977; 34 (8): 498-504.
50. Popper JS, Bingham WG, Armstrong FS: Sarcoid granuloma of the cerebellum. Neurology 1960; 10: 942-6.
51. Junger SS, Stern BJ, Levine SR, Sipos E, Marti-Masso JF: Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 1993; 43: 333-7.
52. Nesbit GM, Miller GM, Baker HL, Ebersold MJ, Scheithauer BW: Spinal cord sarcoidosis: a new finding at MR imaging with Gd-DTPA enhancement. Radiology 1989; 173: 839-43.
53. Morita H, Hayashi R, Tako K, Tsukuda N, Yanagisara N: Spinal cord sarcoidosis: MRI findings in response to treatment. Eur Neurol 1992; 32 (3): 126-9.
54. Yamashita M, Yasuda H, Sonobe M, Hisanaga T, Shigeta Y: A case of spinal cord sarcoidosis with interesting MRI findings Clin Neurol 1991; 31 (7): 734-7.
55. Zajicek J: Sarcoidosis of the cauda equina: a report of three cases. J Neurol 1990; 237: 424-6.
56. Nemni R, Galassi G, Cohen M, et al: Symmetric sarcoid polyneuropathy: analysis of a sural nerve biopsy. Neurology 1981; 31 (10): 1217-23.
57. Oh SJ: Sarcoid polyneuropathy: a histologically proved case. Ann Neurol 1980; 7 (2): 178-81.
58. Galassi G, Gilbertoni M, Mancini A, et al: Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases. Eur Neurol 1984; 23 (6): 459-65.
59. Payne CR, Tait D, Batten JC: Sarcoidosis and chronic sensory neuropathy. Postgrad Med J 1980; 56 (661): 781-2.
60. Challenor YB, Felton CP, Brust JCM: Peripheral nerve involvement in sarcoidosis: an electrodiagnostic study. J Neurol Neurosurg Psychiatry 1984; 47: 1219-22.
61. Zuniga G, Ropper AH, Frank J: Sarcoid peripheral neuropathy. Neurology 1991; 41: 1558-61.
62. Said G, Lacroix C, Plante-Bordeneuve V, et al: Nerve granulomas and vasculitis in sarcoid peripheral neuropathy; a clinicopathological study of 11 cases. Brain 2002; 125: 264-75.
63. Otake S: Sarcoidosis involving skeletal muscle: imaging findings and relative value of imaging procedures. AJR 1994; 162: 369-75.
64. Tews DS, Pongratz DE: Immunohistological analysis of sarcoid myopathy. J Neurol Neurosurg Psychiatry 1995; 59: 322-5.
65. Michotte A, Dequenne P, Jacobovitz D, Hildebrand J: Focal neurological deficit with sudden onset as the first manifestation of sarcoidosis: a case report with MRI follow-up. Eur Neurol 1991; 31 (6): 376-9.
66. Sethi KD, el Gammal T, Patel BR, Swift TR: Dural sarcoidosis presenting with transient neurologic symptoms. Arch Neurol 1986; 43(6): 595-7.
67. Duffey P, Bates D. Transient focal neurological deficit in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 171-2.
68. Graham E, James DG: Neurosarcoidosis. Sarcoidosis 1988; 5: 125-31.
69. Wiederholt WC, Siekert RG: Neurological manifestations of sarcoidosis. Neurology 1965; 15: 1147-54.
70. James DG, Sharma OP: Neurological complications of sarcoidosis. Proc R Soc Med 1967; 60: 1169-72.
71. Luke RA, Stern BJ, Krumholz A, Johns CJ: Neurosarcoidosis: the long term clinical course. Neurology 1987; 37: 461-3.
72. Williams DW, Elster AD, Kramer SI: Neurosarcoidosis: gadolinium-enhanced MR imaging. J Comp Assisted Tomog 1990; 14 (5): 704-7.
73. Lexa FJ, Grossman RI: MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR 1994; 15: 973-82.
74. Kohsyu H, Aoyagi M, Tojima H, et al: Facial nerve enhancement in Gd-MRI in patients with Bell's palsy. Acta Oto-Laryngologica (suppl) 1994; 511: 165-9.
75. Sherman JL, Stern BJ: Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. Am J Roentgenol 1990; 155 (6): 1293-301.
76. McKinstry CS, Worthington BS, Niendorf HP, Young IR: Demonstration of meningeal contrast enhancement on magnetic resonance imaging. Acta Radiol (suppl) 1986; 369: 564-7.
77. Kadakia JK, Collette PM, Sharma OP: Role of magnetic resonance imaging in neurosarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 1993; 10: 98-9.
78. Miller DH, Kendall BE, Barter S, et al: Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988; 38: 378-83.
79. Zouaoui A, Maillard JC, Dormont D, Chiras J, Marsault C: Apport de l'IRM dans la neurosarcoïdese. J Neuroradiol 1992; 19: 271-84.
80. Sauter MK, Panitch HS, Krisst DA: Myelopathic neurosarcoidosis: diagnostic value of enhanced MRI. Neurology 1991; 41: 150-1.
81. Levivier M, Baleriaux D, Matos C, Pirotte B, Brotchi J: Sarcoid myelopathy. Neurology 1991; 41: 1529-30.
82. Khaw KT, Manji H, Britton J, Schon F: Neurosarcoidosis - demonstration of meningeal disease by gadolinium enhanced magnetic resonance imaging. J Neurol Neurosurg Psychiatry 1991; 54: 499-502.
83. Smith AS, Meisler DM, Weinstein MA, et al: High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis? AJR 1989; 153(1): 147-52.
84. Gaines JD, Eckman PB, Remington JS: Low CSF glucose level in sarcoidosis involving the central nervous system. Arch Intern Med 1970; 125 (2): 33-6.
85. Stern BJ, Griffin DE, Luke RA, Krumholz A, Johns CJ: Neurosarcoidosis: Cerebrospinal fluid lymphocyte subpopulations. Neurology 1987; 37: 878-81.
86. Juozevicius JL, Rynes RI. Increased helper/suppressor T-lymphocyte ratio in the cerebrospinal fluid of a patient with neurosarcoidosis. Ann Intern Med 1986; 104 (6): 807-8.
87. Li C, Yam LT: Cytologic and immunocytochemical studies of cerebrospinal fluid in meningeal sarcoidosis. Acta Cytologica 1992; 36 (6): 963-7.
88. Scott TF, Seay AR, Goust JM: Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis. Neurology 1989; 39: 1637-9.
89. Borucki SJ, Nguyen BV, Ladoutis CT, McKendall RR: Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol 1989; 46: 270-3.
90. Mitchell JD, Yap PL, Milne LA, Lachmann PJ, Pentland B: Immunological studies on the cerebrospinal fluid in neurological sarcoidosis. J Neuroimmunology 1985; 7 (4): 249-53.
91. McLean BN, Miller D, Thompson EJ: Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995; 58: 548-54.
92. Oksanen V, Fyhrquist F, Gronhagen-Riska C, Somer H: Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology 1985; 35: 1220-3.
93. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y: Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 1992; 111: 65-72.
94. 2-microglobulin in neurosarcoidosis. J Neurol Sci 1986; 73: 79-87.
95. Garcia-Moncó C, Berciano J: Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation. J Neurol Neurosurg & Psychiatry 1988; 51: 1594-9.
96. Mitchell DM, Mitchell DN, Collins JV, Emerson CJ: Transbronchial lung biopsy through fibreoptic bronchoscope in diagnosis of sarcoidosis. Br Med J 1980; 280: 679-81.
97. Lieberman J: Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365-72.
98. Zorn SK, Stevens CA, Schachter EN, Gee JB: The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme. Lung 1980; 157: 87-94.
99. Katz P, Fauci AS, Yeager H, Reen BM: Serum angiotensin-converting enzyme and lysozyme in granulomatous diseases of unknown cause. Ann Intern Med 1981; 94 (3): 359-60.
100. Jarman PR, Whyte MK, Glass DM, Peters AM: Case report: imaging of central nervous system sarcoidosis with gallium-67 single photon emission computed tomography. Br J Radiol 1996; 69: 192-4.
101. Makhija MC, Anayiotos CP: Gallium scan in intracerebral sarcoidosis. Clin Nucl Med 1981; 6 (7): 324-7.
102. Ayres JG, Hicks BH, Maisey MN: Gallium-67 uptake in meningeal sarcoidosis. Clin Nucl Med 1986; 11 (7): 507-8.
103. Sulavik SB, Palestro CJ, Spencer RP, Sawyer AJ, Goldsmith SJ, Tierstein AS: Extrapulmonary sites of radiogallium accumulation in sarcoidosis. Clin Nucl Med 1990; 15: 876-8.
104. Alavi A, Palevsky HI: Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. J Nucl Med 1992; 33: 751-5.
105. Du Bois RM: Corticosteroids in sarcoidosis: friend or foe? Eur Resp J 1994; 7: 1203-9.
106. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52: 875-9.
107. Sharma OP: Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 1998; 55: 1248-54.
108. Anonymous: Chloroquine in the treatment of sarcoidosis. A report from the research committee of the British tuberculosis association. Tubercle 1967; 48 (4): 257-72.
109. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G: The treatment of neurosarcoidosis with cyclosporine. Arch Neurol 1992; 49: 1065-72.
110. Kavanaugh AF, Andrew SL, Cooper B, Lawrence EC, Huston DP: Cylcosporine therapy of central nervous system sarcoidosis. Am J Med 1987; 82: 387.
111. Lower EE, Broderick JP, Brott TG, Baughman RP: Diagnosis and management of neurological sarcoidosis. Arch Int Med 1997; 157: 1864-8.
112. Baughman RP, Ohmichi M, Lower EE: Combination therapy for sarcoidosis (review). Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 133-7.
113. Bejar JM, Kerby GR, Ziegler DK, Festoff BW. Treatment of central nervous system sarcoidosis with radiotherapy. Ann Neurol 1985; 18: 258-60.
114. Thamoush AJ, Amir M, Connor W, et al: CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 191-7.
115. Usui Y, Kaiser E, See R, Rao N, Sharma OP: Update of ocular manifestations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 167-75.